Table 1.
Subtypes of triple negative breast cancer (TNBC) based on analysis of gene expression profiles
| TNBCtype | TNBCtype-4 | Subtypes of TNBC |
|---|---|---|
| (Lehman et al. [27]) | (Lehman et al. [30]) | (Burstein et al. [29]) |
| Basal-like 1 (BL1) | basal-like1 (BL1) | basal-like immune-suppressed (BLIS) |
| Basal-like 2 (BL2) | basal-like 2 (BL2) | |
| Immunomodulatory (IM) | basal-like immune-activated (BLIA) | |
| Mesenchymal (M) | mesenchymal (M) | mesenchymal (MES) |
| Mesenchymal stem-like (MSL) | ||
| Luminal androgen receptor (LAR) | luminal androgen receptor (LAR) | luminal androgen receptor (LAR) |